Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR(*)D

Affecting about 1 in 12 Americans annually, depression is a leading cause of the global disease burden. While a range of effective antidepressants are now available, failure and relapse rates remain substantial, with intolerable side effect burden the most commonly cited reason for discontinuation....

Descripción completa

Detalles Bibliográficos
Autores principales: Adkins, D E, Clark, S L, Åberg, K, Hettema, J M, Bukszár, J, McClay, J L, Souza, R P, van den Oord, E J C G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410623/
https://www.ncbi.nlm.nih.gov/pubmed/22760553
http://dx.doi.org/10.1038/tp.2012.57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410623/
https://www.ncbi.nlm.nih.gov/pubmed/22760553
http://dx.doi.org/10.1038/tp.2012.57

Ejemplares similares